ACLU and gene patents

Although this is not related to plants, this certainly has implications for plant genetics. I have just received notice that th ACLU has filed a lawsuit against Myriad Genetics, the company that owns the patents on the BCRA1 and BCRA2 breast and ovarian cancer genes in humans.

According to this press release, the ACLU charges “that the patenting of two human genes linked to breast and ovarian cancer will inhibit medical research. The organization also claims that the patents are invalid and unconstitutional.”

It continues:

“This is going to turn into one of the watershed events in the evolution of the bioindustry,” says John Sterling, Editor in Chief of GEN. “The pros and cons of patenting genes have been an ongoing, and often acrimonious series of debates, since the in re Chakrabarty decision in 1980. But this particular case seems to have taken on a life of its own with over fifteen plaintiffs. For while the lawsuit specifically centers on the patentability of two cancer-related genes, the ACLU says it plans to challenge the entire concept of patenting genes. What we have here is one group, the ACLU and its allies, contending that gene patents stifle life science research and potentially harm the health of thousands of patients. On the other side are biotech companies who maintain that without gene patents research incentives are seriously diminished and innovation is smothered.”

Continue reading…

Share

Are GMOs a plot to rule the world?

Editor’s note: The following post was part of an April Fools Joke. Go here for more details.

By William Harvey:

Hello readers, I am William Harvey, the Director of Global GMO Policy at Greenpeace International. In exchange for support of this blog’s continued operations, I will be posting regularly at Biofortified, and my office staff will monitor and moderate the continued discussion. We have made a few minor changes to the look of the blog. Now for my first blog post.

Everyone knows that every Genetically Modified Organisms (GMOs) are patented by corporations. There is not a single GMO that can be grown without the explicit permission through a signed contract. This puts the power in the hands of multinationals, taking it away from the indigenous people of Hawaii, Southeast Asia, Africa, and even farmers in the U.S. are having their right stripped away. The right to save seed is fundamental to growing food, and anything that removes this right is morally wrong.

This is why Greenpeace has a strong stance against genetic modification, because as a corporate technology it inherently requires that farmers be unable to save seed. We also seek to eliminate hybrid crops, because these are another method for maintaining the dominance of seed companies over farmers. Hybrids do not breed true – and so farmers have to keep re-buying seed. Recently, we have added seedless watermelons to our growing list of ‘farmer suicide’ foods, because the triploid seeds must be purchased every year.

As we have learned from cases such as Schmeiser v Monsanto, the biotech companies will stop at nothing to prevent farmers from saving their seeds.

Continue reading…

Share

To Label or Not to Label

If GE crops are considered safe by most scientists, why not simply label the produce from these crops and let people decide for themselves? Most people like to know what they are eating and make their own choices.

I am a label reader. If there is an excess of added sugar or too many ingredients with names that I don’t recognize then I don’t buy the product. Not all information, however, is useful.

A few months ago our local food coop began posting red “consumer alert” signs that say, “Conventional foods that contain corn, soy, or canola may be genetically engineered.” I find these signs more annoying than helpful.

Continue reading…

Share

Where are the Crops?

Michael Heller, law prof at Columbia, has a nice opinion piece in this month’s Forbes concerning biotech patents. His article, Where are the Cures? is about medical biotech, but the ideas apply to agricultural biotech as well. The problem isn’t patents on finished products, but patents on the building blocks needed to make those products – the kernels, not the cob. Michael blames the dearth of new drugs on “patent gridlock”. He writes: “Now,

Continue reading…

Share

Solving the IP problem, one rupee at a time

One valid argument against GMOs is that big corporations control the tech and can charge the farmers sky high prices for the seed. For a long time, I’ve been saying that I don’t like the system, but if countries want to protect their farmers then they should pass some legislation. Well, it’s happened!

The Maharashtra government has fixed the price of genetically modified Bt cotton seeds at 750 rupees [about US $17.40]

Continue reading…

Share